ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years
Wan-Ying Jia
Matched on OpenAlex author ID A5051536424. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2023: 1 paper · 2024: 1 paper
Papers 2
- Efficacy of color Doppler ultrasound and contrast-enhanced ultrasound in identifying vascular invasion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13244-024-01779-5↗
- Pancreatic ductal adenocarcinoma with synchronous and metachronous hepatic metastasis predicted by contrast-enhanced ultrasound. Co-author DOI 10.21037/qims-22-1132↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuejuan Cheng · 2 shared papers, 2023–2024 · strength 0.33
- Paper Efficacy of color Doppler ultrasound and contrast-enhanced ultrasound in identifying vascular invasion in pancreatic du… DOI 10.1186/s13244-024-01779-5↗
- Paper Pancreatic ductal adenocarcinoma with synchronous and metachronous hepatic metastasis predicted by contrast-enhanced ul… DOI 10.21037/qims-22-1132↗
- Menghua Dai · 2 shared papers, 2023–2024 · strength 0.33
- Paper Efficacy of color Doppler ultrasound and contrast-enhanced ultrasound in identifying vascular invasion in pancreatic du… DOI 10.1186/s13244-024-01779-5↗
- Paper Pancreatic ductal adenocarcinoma with synchronous and metachronous hepatic metastasis predicted by contrast-enhanced ul… DOI 10.21037/qims-22-1132↗
- Junchao Guo · 2 shared papers, 2023–2024 · strength 0.33
- Paper Efficacy of color Doppler ultrasound and contrast-enhanced ultrasound in identifying vascular invasion in pancreatic du… DOI 10.1186/s13244-024-01779-5↗
- Paper Pancreatic ductal adenocarcinoma with synchronous and metachronous hepatic metastasis predicted by contrast-enhanced ul… DOI 10.21037/qims-22-1132↗
- Ke Lv · 1 shared paper, 2024 · strength 0.18
- Yuxin Jiang · 1 shared paper, 2023 · strength 0.15
- Ke Lv · 1 shared paper, 2023 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.